What Oscar Health Holders Bought Into Before A 109% Run

Simply Wall St.

Oct 28

If Oscar Health was on your watchlist rather than in your portfolio, the outcome over this stretch may feel like a missed call. Holding Oscar Health from the start of the year would have returned ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2678435796"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2678435796\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2678435796?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7212000-choice1-card/1788993780698","is_english":true,"pubTime":"2026-10-28 09:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2678435796","market":"sg","top_or_hot":-1,"title":"What Oscar Health Holders Bought Into Before A 109% Run","media":"Simply Wall St.","content":"<div>\n<p>If Oscar Health was on your watchlist rather than in your portfolio, the outcome over this stretch may feel like a missed call. Holding Oscar Health from the start of the year would have returned ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/what-oscar-health-holders-bought-into-before-a-109-run\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Oscar Health Holders Bought Into Before A 109% Run</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Oscar Health Holders Bought Into Before A 109% Run\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-28 09:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/what-oscar-health-holders-bought-into-before-a-109-run><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If Oscar Health was on your watchlist rather than in your portfolio, the outcome over this stretch may feel like a missed call. Holding Oscar Health from the start of the year would have returned ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/what-oscar-health-holders-bought-into-before-a-109-run\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4162","symbol_name":"人寿与健康保险","start_time":0,"source_url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/what-oscar-health-holders-bought-into-before-a-109-run","article_id":"2678435796","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7212000-choice1-card/1788993780698"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/what-oscar-health-holders-bought-into-before-a-109-run","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2678435796","pubTimestamp":1793150417,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If Oscar Health was on your watchlist rather than in your portfolio, the outcome over this stretch may feel like a missed call. Holding Oscar Health from the start of the year would have returned 109.4%, including dividends. That kind of gain invites a simple question. Back in early 2026, when the debate centered on whether its AI-led insurance model could really support durable margins, what specific signals might have flagged that assumption as credible enough to act on?\nNarratives are how...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4162":"人寿与健康保险","OSCG":"2倍做多OSCR ETF-Leverage Shares","BK4551":"寇图资本持仓","HEAL":"Global X HealthTech ETF","OSCR":"Oscar Health, Inc.","OSCX":"2倍做多OSCR ETF-Defiance"},"translate_title":"Oscar Health 持有者在上涨 109% 之前购买了什么","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCG":0.6,"OSCX":0.6,"OSCR":1.97,"HEAL":0.6},"content_text":"If Oscar Health was on your watchlist rather than in your portfolio, the outcome over this stretch may feel like a missed call. Holding Oscar Health from the start of the year would have returned 109.4%, including dividends. That kind of gain invites a simple question. Back in early 2026, when the debate centered on whether its AI-led insurance model could really support durable margins, what specific signals might have flagged that assumption as credible enough to act on? Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value. This theme extends beyond Oscar Health. See which of 34 healthcare AI stocks may still merit a closer look. AdvertisementThe Argument You Would Have Been Weighing Up On Oscar Health The shares cost US$14.37 at the start of the period, so any call on Oscar Health hinged on which story you trusted more. The bullish Narrative put Fair Value at US$45.34, based on Oscar Health adding roughly 30% more members each year and using its +Oscar AI platform to support 10.0% revenue growth and a 10.4% profit margin over a 5 year horizon. The bearish Narrative pointed to a Fair Value of US$11.29, focused on higher claims costs, shifting regulation and policy risk that could pressure net margins and limit future membership growth even with digital adoption trends. NYSE:OSCR Trailing 12-Month Earnings & Revenue History as at Oct 2026 What The Results Changed For The Oscar Health Debate Oscar Health’s Q2 2026 report showed revenue of US$4.88b versus US$2.86b a year earlier, and a swing from a loss of US$228.4m to profit of US$361.8m, with net margin moving from 8.0% negative to 7.4% positive. That shift toward profitability, helped by better medical loss and expense ratios, largely supported the optimistic case. At the same time, regulatory and subsidy risks in the news kept the cautious view alive. The practical takeaway is clear. When a thesis leans on margin expansion from technology and pricing, track net margin and medical loss ratios quarter by quarter. Also test whether guidance is being reaffirmed or reset before applying a similar story to any other insurer. What Oscar Health’s Run Now Prices In Oscar Health trades at US$31.35 today, with the selected Narrative suggesting its Fair Value sits below that level. The focus is less on AI as a concept and more on how much churn and regulatory friction could eat into the benefits of that tech heavy model. You now need to ask what must keep going right for that price to hold. A buyer has to judge whether ACA and CHOICE growth can outweigh potential CMS driven enrollment clean ups so that margins stay supported rather than just offsetting churn. \"While Oscar Health points to AI driven efficiencies and a lower SG&A ratio as support for its cost position, the scale of CMS program integrity reviews that are expected to cancel unauthorized ACA enrollments introduces a structural risk that future AI fuelled membership growth simply replaces churned lives rather than adds net volume, which could cap revenue and pressure operating leverage.\" One Narrative has put a figure on that disagreement. → See the Narrative with its lower Fair Value, assumptions and all Go Straight To The Source By the time a rally makes headlines, you are reading about returns someone else has already earned. Why not go straight to the source and look for your own contrarian opportunity? These three companies trade below our estimated value.  Company 1 - 19% below our estimate - focuses on expanding teahouse franchises while managing store profitability and franchisee incentives. Company 2 - 42% below our estimate - targets large-scale LED installations as digital displays supplant traditional signage and scoreboards. Company 3 - 46% below our estimate - converts construction backlogs into higher-margin data center and modular infrastructure projects.  That is three of the list. See the full list of 29 companies trading below our fair value estimates → This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}